I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Randomized, open-label phase II study of brigatinib and car..:
Kazushige Wakuda
;
Hirotsugu Kenmotsu
;
Yuki Sato
...
https://doi.org/10.1186/s12885-023-11417-w. , 2023
Link:
https://doi.org/10.1186/s12885-023-11417-w
RT Journal T1
Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small cell lung cancer: treatment rationale and protocol design of the B-DASH study (WJOG 14720 L)
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:d9026cc985de4542a52c71143cb58729&Exemplar=1&LAN=DE A1 Kazushige Wakuda A1 Hirotsugu Kenmotsu A1 Yuki Sato A1 Atsushi Nakamura A1 Hiroaki Akamatsu A1 Motoko Tachihara A1 Satoru Miura A1 Toshihide Yokoyama A1 Keita Mori A1 Kazuhiko Nakagawa A1 Nobuyuki Yamamoto PB BMC YR 2023 K1 Non-small cell lung cancer K1 ALK K1 Brigatinib K1 Pemetrexed K1 Chemotherapy K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12885-023-11417-w LK http://dx.doi.org/https://doi.org/10.1186/s12885-023-11417-w DO https://doi.org/10.1186/s12885-023-11417-w SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)